These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35701857)

  • 1. Tirofiban potentiates agonist-induced platelet activation and degranulation, despite effectively inhibiting aggregation.
    Aguiar Bucsai M; Idel C; Wollenberg B; Mannhalter C; Verschoor A
    Platelets; 2022 Nov; 33(8):1192-1198. PubMed ID: 35701857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
    Judge HM; Buckland RJ; Holgate CE; Storey RF
    Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pathological high shear exposure time on platelet activation and aggregation.
    Zhang T; Huang X; Gao X; Liu L; Chen D; Huan X; He C; Li Y
    Clin Hemorheol Microcirc; 2023; 84(2):125-139. PubMed ID: 37066902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet Integrin αIIbβ3 Inhibitor Rescues Progression of Apoptosis in Human Platelets.
    Zhu J; Wang Q; Nie Y; Yan R; Dai K; Zhou B
    Med Sci Monit; 2016 Nov; 22():4261-4270. PubMed ID: 27827357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tirofiban (Aggrastat) protects platelets and decreases platelet-granulocyte binding in an extracorporeal circulation model.
    Straub A; Azevedo R; Beierlein W; Wendel HP; Dietz K; Ziemer G
    Thorac Cardiovasc Surg; 2006 Apr; 54(3):162-7. PubMed ID: 16639676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of platelets aggregation in the process of ductus arteriosus closure of newborn pups].
    Ren Y; Gao X; Zhao D; Wang L; Huang D; Su M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1194-1199. PubMed ID: 36567565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
    Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in the ability of glycoprotein IIb-IIIa antagonists to exert and maintain their inhibitory effects on the binding of fibrinogen.
    Schneider DJ; Baumann PQ; Whitaker DA; Sobel BE
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):41-5. PubMed ID: 15965353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tissue factor-activated platelets by low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonist.
    Ahmad S; Jeske WP; Ma Q; Walenga JM; Fareed J
    Thromb Res; 2001 Apr; 102(2):143-51. PubMed ID: 11323025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.
    Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP
    Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
    Schneider DJ; Taatjes DJ; Sobel BE
    Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils.
    Taylor ML; Ilton MK; Misso NL; Watkins DN; Hung J; Thompson PJ
    Br J Clin Pharmacol; 1998 Aug; 46(2):139-45. PubMed ID: 9723822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet alpha-granule secretion and its modification by SC-57101A, a GPIIb/IIIa antagonist.
    Ogawa T; Sugidachi A; Otsuguro K; Isobe T; Asai F
    Biochem Pharmacol; 2002 May; 63(10):1911-8. PubMed ID: 12034376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
    Xiao Z; Théroux P; Frojmovic M
    Thromb Haemost; 1999 Feb; 81(2):281-5. PubMed ID: 10064007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.
    Naimushin YA; Mazurov AV
    Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of GP IIb/IIIa receptors during platelet activation: influence on efficacy of receptor blockade.
    Matzdorff A; Voss R
    Thromb Res; 2006; 117(3):307-14. PubMed ID: 15894353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of different thrombolytic treatment regimen with abciximab and tirofiban on platelet aggregation and platelet-leukocyte interactions: a subgroup analysis from the GUSTO V and FASTER trials.
    Bertram U; Moser M; Peter K; Kuecherer HF; Bekeredjian R; Straub A; Nordt TK; Bode C; Ruef J
    J Thromb Thrombolysis; 2002 Dec; 14(3):197-203. PubMed ID: 12913399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for platelet alphaIIb beta3 activation despite elevated cytosolic cAMP.
    Riondino S; Gazzaniga PP; Pulcinelli FM
    Thromb Haemost; 2001 Feb; 85(2):320-5. PubMed ID: 11246555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.